CoChat

Cancer Survivorship: The Interface of Aging, Comorbidity, and Quality Care

Rowland, Julia H., Yancik, Rosemary · 2006 · JNCI: Journal of the National Cancer Institute
Cited by 79

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Already including more than 10 million individuals, the number of cancer survivors in the United States will continue to increase into the foreseeable future ( 1 , 2 ) . This trend is being driven by early detection, improved treatments, and better supportive care, but also, importantly, by the aging of the U.S. population. The number (and percentage) of persons aged 65 years and older in the U.S. population is projected to increase from its current level of 35 million (12.4%) to 70 million (20%) persons by 2030 ( 3 ) . Given that the single most important risk factor for developing cancer is aging, these figures are sobering. Aging is also a strong predictor of functional decline and other comorbid conditions. Consequently, understanding the contribution of cancer to the older individual's functional health status and how adverse effects of one chronic health condition can influence another is critical if we are to reduce the human and social burden of cancer. The report by Sweeney et al. ( 4 ) provides a view of this interplay that is heartening but also raises concerns. Using data from a 1997 follow-up of the Iowa Women's Health Study (IWHS) cohort, these investigators found that when compared with women without a cancer history (N = 23 501), most of the 2218 female cancer survivors studied were functioning well after their cancer diagnosis. Most long-term survivors, 5 years or more after a cancer diagnosis, reported no functional limitations. Typical of previously reported patterns, however, women closer to diagnosis reported more limitations in functioning than those farther from treatment. Moreover, women with a cancer history were at increased risk of reporting more limitations in their usual activities of daily living than control subjects without a history of cancer, particularly with respect to their ability to do heavy housework, walk a half-mile, and go up and down stairs. These differences persisted even after controlling for known risk factors that compromise function such as age, lower educational status, precancer problems in physical function, overweight, history of smoking, diabetes, heart disease, high blood pressure, bone fracture, and self-reported levels of low physical activity at baseline. Indeed, the data presented likely underrepresent the true physical burden of surviving cancer because women reporting limitations before developing cancer were excluded from analyses. Further, women with more serious illness or not doing well were less likely to complete the survey, and those with a second or multiple malignancies (N = 202) were deliberately excluded. This latter exclusion is particularly noteworthy given that the longer a person lives after a cancer diagnosis, the more likely he or she is to develop a second cancer. Of current survivors diagnosed between 1975 and 2001, an estimated 8% have had more than one primary cancer ( 5 ) . A unique aspect of this study is the insight provided on the health of older female survivors living years beyond their cancer. Despite constituting the largest sector of the prevalent population (61%) ( 1 ) , cancer survivors aged more than 65 years are rarely the subjects of survivorship research. In fiscal year 2004, the year for which latest figures are available, only 15 (7%) of the 212 studies examining survivors' posttreatment outcomes that were supported National Institutes of Health–wide included samples of these older adults, whereas 39 (18%) were being conducted among survivors 5 or more years posttreatment ( 6 ). The first wave of the baby boomer generation (persons born 1946–1964) turns age 65 in 2011; thus, we must understand and find ways to reduce the adverse impact of surviving cancer on the health of older adults. The current study illustrates well why we must continue to leverage our large investment in both population-based cohort and case–control studies. Both hold the potential to furnish valuable information on the cost of surviving cancer across diverse sectors of our population ( 7 , 8 ) . A major strength of these study designs is their access to information regarding individuals' health status and behaviors both before and after cancer, and critically, as compared with control populations without cancer, as illustrated in research conducted using data from the Nurses' Health Study ( 9 ) . The report by Sweeney and colleagues ( 4 ) highlights important directions for future survivorship research and clinical care. First, we must develop the means to systematically monitor and report comorbid health conditions among patients newly diagnosed with cancer and over time. Surprisingly little is known about the effect of comorbid conditions on cancer diagnosis, treatment, subsequent health, or quality-of-life outcomes. As our society ages, clinicians will be treating more older patients and thus increasing the likelihood that many of the newly diagnosed patients they see will have one or more preexisting age-associated comorbid conditio

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djj154

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 79

Metadata

Authors
Rowland, J. H., & Yancik, R.
Venue
JNCI: Journal of the National Cancer Institute
Published
2006-04-19
Volume
98
Issue
8
Pages
504-505
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2108978927
Cited by
79
References
1
FWCI
2.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer Survivorship: The Interface of Aging, Comorbidity, and Quality Care. https://app.cochat.ai/papers/10.1093/jnci/djj154
The paper
Rowland, J. H., & Yancik, R. (2006). Cancer Survivorship: The Interface of Aging, Comorbidity, and Quality Care. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djj154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.